$GRTS
Gritstone bio Inc

2018 Q4 Form 10-Q Financial Statement

#000119312518325800 Filed on November 14, 2018

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q3 2017 Q3
Revenue $1.091M $96.00K $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.870M $3.090M $1.400M
YoY Change 111.48% 120.71%
% of Gross Profit
Research & Development $15.25M $15.62M $8.084M
YoY Change -3.17% 93.25%
% of Gross Profit
Depreciation & Amortization $1.070M $1.010M $470.0K
YoY Change 64.62% 114.89%
% of Gross Profit
Operating Expenses $19.12M $18.71M $9.488M
YoY Change 8.76% 97.2%
Operating Profit -$18.03M -$18.61M -$9.488M
YoY Change 2.54% 96.18%
Interest Expense $690.0K $26.00K $37.00K
YoY Change 228.57% -29.73%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$17.34M -$18.59M -$9.450M
YoY Change -0.17% 96.72%
Income Tax
% Of Pretax Income
Net Earnings -$17.34M -$18.59M -$9.451M
YoY Change -0.17% 96.68%
Net Earnings / Revenue -1589.18% -19362.5%
Basic Earnings Per Share
Diluted Earnings Per Share -$584.6K -$640.2K -$334.8K
COMMON SHARES
Basic Shares Outstanding 29.04M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q4 2018 Q3 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $153.1M $77.40M
YoY Change
Cash & Equivalents $52.18M $65.94M $99.03M
Short-Term Investments $100.9M $11.50M
Other Short-Term Assets $449.0K $904.0K
YoY Change 372.63%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $157.6M $84.15M
YoY Change 78.16%
LONG-TERM ASSETS
Property, Plant & Equipment $29.49M $27.01M
YoY Change 8.39%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $250.0K $2.000M
YoY Change 0.0%
Total Long-Term Assets $31.92M $29.05M
YoY Change 10.76%
TOTAL ASSETS
Total Short-Term Assets $157.6M $84.15M
Total Long-Term Assets $31.92M $29.05M
Total Assets $189.6M $113.2M
YoY Change 61.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.825M $3.874M
YoY Change 22.62%
Accrued Expenses $740.0K $2.238M
YoY Change -50.34%
Deferred Revenue $5.340M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $15.11M $13.72M
YoY Change 97.44%
LONG-TERM LIABILITIES
Long-Term Debt $10.50M $10.50M
YoY Change
Other Long-Term Liabilities $12.00K $25.00K
YoY Change -87.5%
Total Long-Term Liabilities $12.00K $25.00K
YoY Change -87.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $15.11M $13.72M
Total Long-Term Liabilities $12.00K $25.00K
Total Liabilities $40.44M $40.51M
YoY Change 102.0%
SHAREHOLDERS EQUITY
Retained Earnings -$126.4M -$109.1M
YoY Change 105.11%
Common Stock $16.00K $2.000K
YoY Change 1500.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $149.1M $72.69M
YoY Change
Total Liabilities & Shareholders Equity $189.6M $113.2M
YoY Change 61.6%

Cashflow Statement

Concept 2018 Q4 2018 Q3 2017 Q3
OPERATING ACTIVITIES
Net Income -$17.34M -$18.59M -$9.451M
YoY Change -0.17% 96.68%
Depreciation, Depletion And Amortization $1.070M $1.010M $470.0K
YoY Change 64.62% 114.89%
Cash From Operating Activities -$12.99M $1.900M -$7.590M
YoY Change -9.41% -125.03%
INVESTING ACTIVITIES
Capital Expenditures -$2.280M -$520.0K -$4.320M
YoY Change -34.86% -87.96%
Acquisitions
YoY Change
Other Investing Activities -$89.17M $15.51M $12.13M
YoY Change 100.7% 27.86%
Cash From Investing Activities -$91.46M $15.00M $7.810M
YoY Change 90.82% 92.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 90.70M 11.50M 92.56M
YoY Change 2699.38% -87.58%
NET CHANGE
Cash From Operating Activities -12.99M 1.900M -7.590M
Cash From Investing Activities -91.46M 15.00M 7.810M
Cash From Financing Activities 90.70M 11.50M 92.56M
Net Change In Cash -13.75M 28.40M 92.78M
YoY Change -76.71% -69.39%
FREE CASH FLOW
Cash From Operating Activities -$12.99M $1.900M -$7.590M
Capital Expenditures -$2.280M -$520.0K -$4.320M
Free Cash Flow -$10.71M $2.420M -$3.270M
YoY Change -1.2% -174.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29038308 shares
CY2017Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
99028000
CY2018Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3874000
CY2018Q3 us-gaap Accrued Rent Current
AccruedRentCurrent
296000
CY2018Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5000
CY2018Q3 us-gaap Assets
Assets
113201000
CY2018Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2238000
CY2018Q3 us-gaap Assets Current
AssetsCurrent
84150000
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5675000
CY2018Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3885000
CY2018Q3 us-gaap Capital Lease Obligations
CapitalLeaseObligations
10526000
CY2018Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
24000
CY2018Q3 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
10502000
CY2018Q3 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
5257000
CY2018Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
48720000
CY2018Q3 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
843000
CY2018Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2018Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
5000
CY2018Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
48715000
CY2018Q3 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
818000
CY2018Q3 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
630000
CY2018Q3 us-gaap Capital Leases Future Minimum Payments Remainder Of Fiscal Year
CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear
197000
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
177872000
CY2018Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6728000
CY2018Q3 us-gaap Prepaid Rent
PrepaidRent
1182000
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
65936000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66928000
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
172250000 shares
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2489871 shares
CY2018Q3 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
4627000
CY2018Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
37229000
CY2018Q3 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
868000
CY2018Q3 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
794000
CY2018Q3 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
1737000
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2489871 shares
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
2000
CY2018Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
3000000
CY2018Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1567000
CY2018Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5210000
CY2018Q3 us-gaap Deferred Revenue
DeferredRevenue
19904000
CY2018Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
14694000
CY2018Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
8000000
CY2018Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2400000
CY2018Q3 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2018Q3 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2018Q3 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2018Q3 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2018Q3 us-gaap Liabilities
Liabilities
40510000
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
113201000
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
13722000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2673000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
396000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
8774000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
2329000
CY2018Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
11486000
CY2018Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
283000
CY2018Q3 us-gaap Other Assets Current
OtherAssetsCurrent
904000
CY2018Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
25000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1118000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1803000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
455000
CY2018Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
19409132 shares
CY2018Q3 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
178283000
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
139228319 shares
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27012000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
72691000
CY2018Q3 grts Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
1659000
CY2018Q3 grts Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
2039000
CY2018Q3 grts Prepaid Expense For Research And Development
PrepaidExpenseForResearchAndDevelopment
1638000
CY2018Q3 grts Prepaid Expense For Research And Development Non Current
PrepaidExpenseForResearchAndDevelopmentNonCurrent
415000
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
19409132 shares
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2721520 shares
CY2018Q3 us-gaap Restricted Cash
RestrictedCash
992000
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-109063000
CY2018Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
32687000
CY2018Q3 us-gaap Security Deposit
SecurityDeposit
632000
CY2018Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
66928000
CY2018Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
992000
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
4200000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
13245000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2416671 shares
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.25
CY2018Q3 grts Prepaid Ipo Costs
PrepaidIpoCosts
3004000
CY2018Q3 grts Residual Value Of Lease Financing Obligation
ResidualValueOfLeaseFinancingObligation
9896000
CY2018Q3 grts Lease Financing Obligations Noncurrent
LeaseFinancingObligationsNoncurrent
10502000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12410000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3935000
CY2017Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
381000
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-74000
CY2017Q4 us-gaap Assets
Assets
117300000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1490000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
88479000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2790000
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2045000
CY2017Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
79898000
CY2017Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2017Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
74000
CY2017Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
79824000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39007000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
39999000
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
160000000 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2152525 shares
CY2017Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
32878000
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2152525 shares
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2017Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0
CY2017Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1749000
CY2017Q4 us-gaap Deferred Revenue
DeferredRevenue
0
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2227000
CY2017Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2017Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2017Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2017Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2017Q4 us-gaap Liabilities
Liabilities
20018000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
117300000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7652000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
250000
CY2017Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
46946000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
426000
CY2017Q4 us-gaap Other Assets Current
OtherAssetsCurrent
579000
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
96000
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
17797529 shares
CY2017Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
157268000
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
125362551 shares
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
156937000
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2526000
CY2017Q4 us-gaap Prepaid Rent
PrepaidRent
93000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27211000
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
17797529 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
626229 shares
CY2017Q4 us-gaap Restricted Cash
RestrictedCash
992000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-61627000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
30001000
CY2017Q4 us-gaap Security Deposit
SecurityDeposit
368000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
39999000
CY2017Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
992000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1351840 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.89
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
97282000
CY2017Q4 grts Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
683000
CY2017Q4 grts Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
1610000
CY2017Q4 grts Reimbursements Receivable From Land Lord
ReimbursementsReceivableFromLandLord
1226000
CY2017Q4 grts Prepaid Expense For Research And Development
PrepaidExpenseForResearchAndDevelopment
628000
CY2017Q4 grts Lease Financing Obligations Noncurrent
LeaseFinancingObligationsNoncurrent
10521000
CY2018Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1449 pure
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
64000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
24000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
175000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
14679000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
92570000
us-gaap Operating Expenses
OperatingExpenses
24183000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20631000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
811000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19353549 shares
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
807000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
86618000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24005000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1300000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-12.27
us-gaap Depreciation
Depreciation
1316000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
637000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4244000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
255000
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-209000
us-gaap Net Income Loss
NetIncomeLoss
-24008000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8017000
us-gaap Operating Income Loss
OperatingIncomeLoss
-24183000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
900000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
38967000
us-gaap Profit Loss
ProfitLoss
-24008000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
16302000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
14000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
31000
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
92556000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19939000
us-gaap Share Based Compensation
ShareBasedCompensation
811000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
20000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1957381 shares
grts Increase Decrease In Deposit And Other Assets Current
IncreaseDecreaseInDepositAndOtherAssetsCurrent
-172000
grts Increase Decrease In Accrued And Other Liabilities Non Current
IncreaseDecreaseInAccruedAndOtherLiabilitiesNonCurrent
483000
grts Assets Acquired Under Financing Lease Obligation
AssetsAcquiredUnderFinancingLeaseObligation
9300000
grts Receivable For Lessor Funded Financing
ReceivableForLessorFundedFinancing
1226000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
204000
dei Amendment Flag
AmendmentFlag
false
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1674000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22109473 shares
us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
20000000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
211000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
26929000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-47367000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-96000
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-182000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2475000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
120000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
32358000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19737000
us-gaap Operating Expenses
OperatingExpenses
47652000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2900000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-20.27
us-gaap Depreciation
Depreciation
2885000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
dei Document Type
DocumentType
10-Q
us-gaap Dividends Preferred Stock
DividendsPreferredStock
0
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y2M23D
dei Entity Registrant Name
EntityRegistrantName
GRITSTONE ONCOLOGY, INC.
dei Entity Small Business
EntitySmallBusiness
false
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
dei Entity Central Index Key
EntityCentralIndexKey
0001656634
dei Document Period End Date
DocumentPeriodEndDate
2018-09-30
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
19904000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
173000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7940000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
179000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25166000
us-gaap Net Income Loss
NetIncomeLoss
-47436000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3375000
us-gaap Operating Income Loss
OperatingIncomeLoss
-47556000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1100000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
69000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
37220000
us-gaap Profit Loss
ProfitLoss
-47436000
us-gaap Preferred Stock Redemption Terms
PreferredStockRedemptionTerms
A redemption event will only occur upon the liquidation or winding up of the Company, a greater than 50% change in control, or the sale of substantially all of the assets of the Company.
us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08 pure
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1487000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
79000
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
20935000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
99411 shares
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
96000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39712000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.31
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.49
us-gaap Share Based Compensation
ShareBasedCompensation
1674000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y14D
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.57
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1300000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b><i>Use of Estimates</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the condensed financial statements and the reported amounts of revenue and expenses in the condensed financial statements and accompanying notes during the reporting period. On an ongoing basis, management evaluates its estimates, including those related to revenue recognition, clinical and preclinical study trial accruals, fair value of assets and liabilities, the fair value of leased buildings and other assumptions associated with lease financing transactions, and the fair value of common stock and stock-based compensation. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates.</p> </div>
grts Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGranted
1231483 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
520000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1231483 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2339705 shares
dei Trading Symbol
TradingSymbol
GRTS
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
67241 shares
grts Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeituresInPeriod
99411 shares
grts Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Options Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsAuthorized
3197246 shares
grts Maximum Contractual Maturities Period
MaximumContractualMaturitiesPeriod
P1Y
grts Share Based Compensation Arrangements By Share Based Payment Award Options Repurchased In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsRepurchasedInPeriodWeightedAverageExercisePrice
0.35
grts Increase Decrease In Deposit And Other Assets Current
IncreaseDecreaseInDepositAndOtherAssetsCurrent
429000
grts Increase Decrease In Accrued And Other Liabilities Non Current
IncreaseDecreaseInAccruedAndOtherLiabilitiesNonCurrent
745000
grts Payment For Deferred Ipo Costs
PaymentForDeferredIpoCosts
1277000
grts Deferred Stock Offering Costs Included In Accounts Payable And Accrued Liabilities
DeferredStockOfferingCostsIncludedInAccountsPayableAndAccruedLiabilities
1727000
grts Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Repurchased
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantRepurchased
30117 shares
grts Tax Cuts And Jobs Act Of2017 Limitation Of Net Operating Loss Deductions As Percentage Of Current Year Taxable Income
TaxCutsAndJobsActOf2017LimitationOfNetOperatingLossDeductionsAsPercentageOfCurrentYearTaxableIncome
0.80 pure
CY2017 us-gaap Dividends Preferred Stock
DividendsPreferredStock
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
305000
CY2017Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19353549 shares
CY2017Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9449000
CY2017Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
500000
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.59
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1404000
CY2017Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
37000
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
9488000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-9451000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9488000
CY2017Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
300000
CY2017Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2000
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8084000
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2057040 shares
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
538000
CY2018Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22109473 shares
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18561000
CY2018Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1000000
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-7.60
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3088000
CY2018Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
26000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
18710000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-18588000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-18614000
CY2018Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
500000
CY2018Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
27000
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
96000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15622000
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2445547 shares

Files In Submission

Name View Source Status
0001193125-18-325800-index-headers.html Edgar Link pending
0001193125-18-325800-index.html Edgar Link pending
0001193125-18-325800.txt Edgar Link pending
0001193125-18-325800-xbrl.zip Edgar Link pending
d618135d10q.htm Edgar Link pending
d618135dex311.htm Edgar Link pending
d618135dex312.htm Edgar Link pending
d618135dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
grts-20180930.xml Edgar Link completed
grts-20180930.xsd Edgar Link pending
grts-20180930_cal.xml Edgar Link unprocessable
grts-20180930_def.xml Edgar Link unprocessable
grts-20180930_lab.xml Edgar Link unprocessable
grts-20180930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending